r 59022 has been researched along with dioctanoyl ethylene glycol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldanzi, G; Bertoni, A; Capello, D; Fresu, LG; Gesu, A; Graziani, A; Massarotti, A; Ruffo, E; Snow, AL; Talmon, M; Tron, GC; Varma, KSS; Velnati, S | 1 |
| Grinstein, S; Nasmith, P | 1 |
2 other study(ies) available for r 59022 and dioctanoyl ethylene glycol
| Article | Year |
|---|---|
Identification of a novel DGKα inhibitor for XLP-1 therapy by virtual screening.
Topics: Cell Death; Computer Simulation; Diacylglycerol Kinase; Drug Evaluation, Preclinical; Humans; Lymphoproliferative Disorders; Piperidines; Protein Kinase Inhibitors; Pyrimidinones; Quinazolinones; Ritanserin; Thiazoles | 2019 |
Diacylglycerol kinase inhibitors R59022 and dioctanoylethylene glycol potentiate the respiratory burst of neutrophils by raising cytosolic Ca2+.
Topics: Calcium; Cell Membrane Permeability; Cytosol; Diacylglycerol Kinase; Drug Synergism; Ethylene Glycols; Humans; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxygen Consumption; Phosphotransferases; Pyrimidinones; Thiazoles | 1989 |